Alpharma’s Embeda Has “Incremental Benefit” In Reducing Opioid Abuse, FDA Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee expresses concern over variability in benefit seen among patients; many still experience euphoria sought by opioid abusers.